Chronic Lymphocytic Leukemia | Exploring Clinical Investigator Perspectives on the Optimal Management of Chronic Lymphocytic Leukemia (for Medical and Hematologic Oncologists)

published 8 months ago by Dr Neil Love

Featuring perspectives from Dr Jennifer Woyach on the following topics: Practical considerations in treatment of CLL for practicing clinicians — Jennifer Woyach, MD (0:00) Case: A man in his early 60s with CLL with an IGHV mutation and deletion 13q receives ibrutinib/obinutuzumab on the control arm of the ECOG-EA9161 trial (26:25) Case: A man in his mid-70s with relapsed/refractory CLL (30:45) Case: A woman in her late 60s initially diagnosed with CLL with deletion 17p but no IGHV mutation undergoes Richter’s transformation (32:03) Biomarker assessment to guide treatment selection in CLL (46:30) Management of treatment-naïve CLL (52:42) Treatment options for relapsed/refractory CLL CME information and select publications (1:25:14) CME information and select publications

more episodes from Research To Practice | Oncology Videos